Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04524689
Title Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC (CARMEN-LC05) (CARMEN-LC05)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sanofi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
cCare/California Cancer Associates Site Number : 8400005 Encinitas California 92024 United States Details
KU Medical Center_Investigational Site Number :8400002 Westwood Kansas 66205 United States Details
Renovatio Clinical_Investigational Site Number :8400004 The Woodlands Texas 77380 United States Details
Virginia Cancer Specialists_Investigational Site Number :8400001 Fairfax Virginia 22031 United States Details
Centro Avancado de Oncologia CECAN - Liga Contra o Cancer Site Number : 0760004 Natal Rio Grande Do Norte 59062-000 Brazil Details
Centro de Investigacion y Desarrollo Oncologico (CIDO) Hochstetter 599 of. 602-603-1001, Temuco_Investigational Site Number :1520005 Temuco La Araucanía 4780000 Chile Details
ONCOCENTRO APYS Av. La Marina 1702, 2do piso, Viña del Mar_Investigational Site Number :1520003 Viña del Mar Valparaíso 2520598 Chile Details
Orlandi Oncologia General Salvo 159, Providencia_Investigational Site Number :1520002 Santiago 7500713 Chile Details
ICEGCLINIC Avenida Serafín Zamora 190 Torre B, piso 4. La Florida_Investigational Site Number :1520006 Santiago 8241470 Chile Details
Fakultní nemocnice Olomouc Onkologická klinika I.P. Pavlova 6_Site Number :2030001 Olomouc 77900 Czechia Details
Nemocnice AGEL Ostrava - Vitkovice Plicní oddělení Zalužanského 2214/35_Site Number :2030002 Ostrava - Vitkovice 70384 Czechia Details
Institut Sainte-Catherine 250 Chemin de Baigne-Pieds_Investigational Site Number :2500005 Avignon 84918 France Details
CHRU BREST 5 Avenue Foch_Investigational Site Number :2500003 Brest 29200 France Details
Centre François Magendie Hôpital du Haut Lévèque Av.de Magellan_Investigational Site Number :2500001 Pessac 33600 France Details
Pôle régional de Cancérologie 2 rue de la Milèterie BP 577_Investigational Site Number :2500004 Poitiers Cedex 86021 France Details
Investigational Site Number :3480003 Budapest 1083 Hungary Details
Országos Onkológiai Intézet Ráth György u. 7_Investigational Site Number :3480002 Budapest 1122 Hungary Details
Veszprém Megyei Tüdőgyógyintézet 049/2 Hrsz_Investigational Site Number :3480004 Farkasgyepü 8582 Hungary Details
Investigational Site Number : 3760004 Jerusalem 91031 Israel Details
Investigational Site Number : 3760001 Ramat Gan 5266202 Israel Details
Investigational Site Number : 3760002 Tel Aviv 64239 Israel Details
Investigational Site Number : 7240005 La Coruña A Coruña [La Coruña] 15006 Spain Details
Investigational Site Number : 7240007 Oviedo Asturias 33011 Spain Details
Investigational Site Number : 7240006 Badalona Catalunya [Cataluña] 08916 Spain Details
Investigational Site Number : 7240003 Valencia / Valencia Valenciana, Comunidad 46010 Spain Details
Investigational Site Number : 7240002 Las Palmas 35016 Spain Details
Investigational Site Number : 7240004 Madrid 28040 Spain Details
Investigational Site Number : 7240001 Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field